Gilead Sciences, Inc.GILDNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -10.91% |
| Q3 2025 | 34.48% |
| Q2 2025 | 10.59% |
| Q1 2025 | -8.77% |
| Q4 2024 | 176.13% |
| Q3 2024 | -66.41% |
| Q2 2024 | 161.18% |
| Q1 2024 | -368.11% |
| Q4 2023 | -38.54% |
| Q3 2023 | 57.54% |
| Q2 2023 | -2.35% |
| Q1 2023 | -24.79% |
| Q4 2022 | -20.09% |
| Q3 2022 | 39.82% |
| Q2 2022 | 929.95% |
| Q1 2022 | -79.04% |
| Q4 2021 | -75.53% |
| Q3 2021 | 71.06% |
| Q2 2021 | -22.28% |
| Q1 2021 | 9.02% |
| Q4 2020 | 32.48% |
| Q3 2020 | 167.08% |
| Q2 2020 | -224.19% |
| Q1 2020 | 119.76% |
| Q4 2019 | 174.20% |
| Q3 2019 | -160.62% |
| Q2 2019 | 8.63% |
| Q1 2019 | 95.54% |
| Q4 2018 | -56.39% |
| Q3 2018 | 15.04% |
| Q2 2018 | 5.90% |
| Q1 2018 | -6.02% |
| Q4 2017 | -39.90% |
| Q3 2017 | -10.39% |
| Q2 2017 | 12.93% |
| Q1 2017 | -6.87% |
| Q4 2016 | -8.05% |
| Q3 2016 | -3.06% |
| Q2 2016 | -2.43% |
| Q1 2016 | -17.26% |